ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TIMOTHY ROSS MD

Internal Medicine

52,772

$3.13M

1162
911 are 65+

30%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

SABRINA BENJAMIN MD

Internal Medicine

36,907

$2.23M

857
672 are 65+

23%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

DENNIS KIM M.D.

Internal Medicine

24,481

$1.5M

669
513 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

TIMOTHY TROEH M.D.

Internal Medicine

22,098

$1.05M

735
623 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

YOUNG LEE MD

Internal Medicine

22,042

$1.91M

950
878 are 65+

2%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 23%

$87
Average prescription price

Avg: $56

ALEX NAJERA MD

Internal Medicine

21,723

$1.27M

613
456 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

32%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

BRYAN JOHNSON M.D.

Internal Medicine

21,611

$1.04M

629
519 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

JAIME NOVAIS MD

Internal Medicine

21,215

$1.18M

846
770 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

JAMES WILSON MD

Internal Medicine

21,058

$1.01M

774
659 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

JULIO BUENAVENTURA MD

Internal Medicine

20,212

$1.1M

458
366 are 65+

28%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $56

RICHARD KIRKPATRICK M.D.

Internal Medicine

19,748

$1.51M

864
653 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 23%

$77
Average prescription price

Avg: $56

LEONICO PANLASIGUI M.D.

Internal Medicine

19,489

$916K

503
429 are 65+

36%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

JOSEPH PALERMO DO

Internal Medicine

19,377

$966K

635
542 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

ATIF MIAN MD

Internal Medicine

18,587

$965K

560
467 are 65+

23%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

LESTER SAUVAGE MD

Internal Medicine

18,144

$826K

515
489 are 65+

23%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

GREGG OSTERGREN DO

Internal Medicine

17,522

$1.14M

661
595 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $56

BONG SUP KIM M.D.

Internal Medicine

16,226

$729K

479
462 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

2%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $56

BENIGNO WALDO DAGAN MD

Internal Medicine

16,187

$850K

465
353 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

TATYANA KUTSY M.D.

Internal Medicine

15,938

$701K

260
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $56

SU YONG PAK M.D.

Internal Medicine

15,201

$939K

547
507 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

DANIEL GINSBERG MD

Internal Medicine

15,023

$971K

582
411 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $56

JONATHAN JIN M.D.

Internal Medicine

14,978

$1.42M

400
360 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

3%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 23%

$95
Average prescription price

Avg: $56

ELLEN KIM MD

Internal Medicine

14,842

$670K

540
425 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $56

SHWETA BALIGA MD

Internal Medicine

14,770

$838K

520
431 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

MARCUS KUBOSUMI MD

Internal Medicine

14,682

$676K

676
555 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank